StockData
MetLife Inc logo

MetLife Inc (MET) stock

METNYSELife InsuranceFiscal year ends December 31Also trades as MET.PA, MET.PE, MET.PF
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 10/3037% above fair value
$99.79−1.71 (-1.68%)

Close on Nov 18, 2026Market cap $63.41BP/E 13.0Yield 2.25%

MetLife revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

MetLife's revenue for the twelve months ending Sep 30, 2026 was $82.56B, up 14.8% year over year. For fiscal 2025 it was $77.08B, up 8.6% from the year before. Over ten years it grew 2.3% a year on average. The highest annual figure on record is $77.08B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$77.08B+8.6%
FY2024Dec 31, 2024$70.99B+6.1%
FY2023Dec 31, 2023$66.91B-2.7%
FY2022Dec 31, 2022$68.77B+0.1%
FY2021Dec 31, 2021$68.70B+1.3%
FY2020Dec 31, 2020$67.84B-2.6%
FY2019Dec 31, 2019$69.62B+2.5%
FY2018Dec 31, 2018$67.94B+9.0%
FY2017Dec 31, 2017$62.31B+2.5%
FY2016Dec 31, 2016$60.79B-0.9%
FY2015Dec 31, 2015$61.34B-16.3%
FY2014Dec 31, 2014$73.32B+7.5%
FY2013Dec 31, 2013$68.20B+0.1%
FY2012Dec 31, 2012$68.15B-3.0%
FY2011Dec 31, 2011$70.24B+34.4%
FY2010Dec 31, 2010$52.25B+28.5%
FY2009Dec 31, 2009$40.66B-20.3%
FY2008Dec 31, 2008$50.98B+8.1%
FY2007Dec 31, 2007$47.15B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$20.52B+18.2%
Q2 FY2026Jun 30, 2026$19.15B+10.5%
Q1 FY2026Mar 31, 2026$19.07B+2.7%
Q4 FY2025Dec 31, 2025$23.81B+27.6%
Q3 FY2025Sep 30, 2025$17.36B-5.9%
Q2 FY2025Jun 30, 2025$17.34B-2.7%
Q1 FY2025Mar 31, 2025$18.57B+15.6%
Q4 FY2024Dec 31, 2024$18.67B-1.9%
Q3 FY2024Sep 30, 2024$18.44B+16.2%
Q2 FY2024Jun 30, 2024$17.82B+7.2%
Q1 FY2024Mar 31, 2024$16.06B+4.3%
Q4 FY2023Dec 31, 2023$19.03B+21.9%
Q3 FY2023Sep 30, 2023$15.87B-28.8%
Q2 FY2023Jun 30, 2023$16.62B+7.4%
Q1 FY2023Mar 31, 2023$15.39B-0.1%
Q4 FY2022Dec 31, 2022$15.61B-11.8%
Q3 FY2022Sep 30, 2022$22.28B+31.8%
Q2 FY2022Jun 30, 2022$15.47B-16.5%
Q1 FY2022Mar 31, 2022$15.41B-1.0%
Q4 FY2021Dec 31, 2021$17.71B-8.8%
Q3 FY2021Sep 30, 2021$16.91B+5.6%
Q2 FY2021Jun 30, 2021$18.52B+31.4%
Q1 FY2021Mar 31, 2021$15.56B-15.0%
Q4 FY2020Dec 31, 2020$19.42B+13.3%
Q3 FY2020Sep 30, 2020$16.02B-14.3%
Q2 FY2020Jun 30, 2020$14.10B-19.4%
Q1 FY2020Mar 31, 2020$18.31B+12.3%
Q4 FY2019Dec 31, 2019$17.14B+9.5%
Q3 FY2019Sep 30, 2019$18.68B+14.7%
Q2 FY2019Jun 30, 2019$17.50B-17.4%
Q1 FY2019Mar 31, 2019$16.30B+10.1%
Q4 FY2018Dec 31, 2018$15.66B-1.1%
Q3 FY2018Sep 30, 2018$16.29B+0.7%
Q2 FY2018Jun 30, 2018$21.19B+38.2%
Q1 FY2018Mar 31, 2018$14.81B-1.1%
Q4 FY2017Dec 31, 2017$15.84B+27.9%
Q3 FY2017Sep 30, 2017$16.17B–
Q2 FY2017Jun 30, 2017$15.33B–
Q1 FY2017Mar 31, 2017$14.96B–
Q4 FY2016Dec 31, 2016$12.39B–

More MetLife figures

See a number that looks wrong?